Clinical Trials in Kirkland, Quebec
2 recruiting
Showing 1–2 of 2 trials
Recruiting
Phase 1Phase 2
Study of Pembrolizumab (MK-3475) Combination Therapies in Metastatic Castration-Resistant Prostate Cancer (MK-3475-365/KEYNOTE-365)
Metastatic Castration-resistant Prostate Cancer
Merck Sharp & Dohme LLC1,200 enrolled21 locationsNCT02861573
Recruiting
DOvEE - Diagnosing Ovarian & Endometrial Cancer Early
Ovarian Neoplasms
McGill University13,600 enrolled8 locationsNCT02296307